BGM Stock Forecast: BGM Group Ltd. Price Predictions for 2026-2027
Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 33 of 100 as at 1 Aug 2026 — in the lower half.
BGM stock analysis: one number for the whole business
Consensus tells you what everyone already believes. The model scores BGM Group Ltd. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Quality (84): The business earns solid, repeatable profits on what it owns.
Issuance (15): The company has been issuing shares or taking on financing, diluting existing holders.
The rank is the raw material. Whether the rules would actually own BGM Group Ltd. — and when they’d sell — is the membership.
BGM stock forecast 2026-2027: analyst price targets & predictions
The bullish and bearish analyst opinions on BGM, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
BGM analyst estimate revisions
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
BGM Group Ltd. (BGM) financial data
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
- Trailing P/E
- 15.0×
- Price / sales
- 3.0×
- Price / book
- 0.2×
- EV / EBITDA
- −4.7×
Cheaper than 47% of US stocks
Cheaper than 42% of US stocks
Cheaper than 89% of US stocks
Cheaper than 78% of US stocks
- Revenue growth (YoY)
- 13.9%
- Earnings growth (YoY)
- —
- Gross margin
- —
- Operating margin
- −15.6%
- Net margin
- 16.6%
Higher than 63% of US stocks
Higher than 24% of US stocks
Higher than 79% of US stocks
- Return on equity
- −5.1%
- Return on assets
- −4.6%
- Dividend yield
- —
Higher than 39% of US stocks
Higher than 32% of US stocks
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
BGM vs competitors
The nearest names by industry and size, scored by the same model — like for like.
This page is one stock. Monday covers all of them.
Computed off the Friday close and sent before the US open.
Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. BGM appears on the weeks it earns a place.
Frequently asked questions about BGM stock
How does Ticker Nerd's model rank BGM?
As at 1 Aug 2026, BGM Group Ltd. ranks 33 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Quality (84 of 100).
What is the BGM stock forecast for 2030?
No analyst covering BGM Group Ltd. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for BGM are extrapolating price history, which says nothing about the business.
How has BGM stock performed over the past year?
BGM Group Ltd. returned -96.6% over the 12 months to 3 Aug 2026, with dividends reinvested. Past performance does not indicate future returns.
What does BGM Group Ltd. do?
BGM Group Ltd. is a Cayman Islands holding company that operates as a pharmaceutical and chemical company through its subsidiaries and variable interest entity in China.
About BGM Group Ltd.
BGM Group Ltd. is a Cayman Islands holding company that operates as a pharmaceutical and chemical company through its subsidiaries and variable interest entity in China. It specializes in manufacturing and distributing active pharmaceutical ingredients, traditional Chinese medicine derivatives, and related products for animal husbandry, human health, and agricultural applications. Key offerings include oxytetracycline products such as tablets and APIs used in treating diseases in livestock and humans; licorice-based medicines and extracts for pharmaceutical formulations; heparin sodium preparations for cardiovascular and hemodialysis treatments; antibacterial pastes for skin conditions; sausage casings; and organic fertilizers to enhance crop yields and soil quality. The company also focuses on AI applications, intelligent robots, algorithmic computing, cloud computing, and biopharmaceuticals, particularly through platforms like DuXiaoBao for insurance sales, underwriting, claims processing, and customer service in the insurance sector. BGM Group Ltd. integrates AI-driven solutions across its operations to optimize pharmaceutical manufacturing and supply chains. Founded in 2019 and based in Chengdu, China, it serves global markets in healthcare, technology, and agriculture.
CEO Mr. Chen Xin · 298 employees · China · https://www.bgmgroupltd.com